SEC Form 4 · purchase transaction · filed Sep 25, 2026
Titterton Lewis H jr purchased $131.9K of Anixa Biosciences Inc
Titterton Lewis H jr (Director) disclosed a purchase of 49,036 shares of Anixa Biosciences Inc (ANIX) at $2.69 per share on Sep 23, 2026, in a Form 4 filed with the SEC on Sep 25, 2026. Disclosed value $131.9K.
The filing, as filed
| Reporting insider | Titterton Lewis H jr |
|---|---|
| Role as filed | Director |
| Company | Anixa Biosciences Inc (ANIX) |
| Security as filed | Common Stock |
| Transaction | Purchase (Form 4 transaction code P: open-market or private purchase) |
| Shares | 49,036 |
| Price per share | $2.69 |
| Disclosed value | $131,906.84 ($131.9K; quantity × the filing's stated price) |
| Trade date | Sep 23, 2026 |
| Filed with the SEC | Sep 25, 2026 |
Source: SEC EDGAR Form 4. Purchase transactions only (code P) — grants, option exercises and tax withholdings are different facts and are never shown as buys. Superseded filings are excluded. Coverage: the US issuers in Flock's Form 4 scope (securities mapped from institutional 13F holdings), not every SEC registrant.
Disclosures shown are public regulatory filings. Data may be delayed or incomplete. Smart-money entities may no longer hold positions shown. Not investment advice.
Related on Flock
The Smart Money Digest
A free weekly email of notable disclosure activity — every line with its filing date and source link. No advice, just filings. Unsubscribe anytime.